COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 138 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q4 2020. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $184,000 | -9.4% | 11,480 | 0.0% | 0.01% | -22.2% |
Q2 2022 | $203,000 | -13.2% | 11,480 | 0.0% | 0.02% | 0.0% |
Q1 2022 | $234,000 | +9.3% | 11,480 | 0.0% | 0.02% | +12.5% |
Q4 2021 | $214,000 | -5.7% | 11,480 | 0.0% | 0.02% | -11.1% |
Q3 2021 | $227,000 | -11.0% | 11,480 | +6.4% | 0.02% | +12.5% |
Q2 2021 | $255,000 | 0.0% | 10,793 | +0.1% | 0.02% | -11.1% |
Q1 2021 | $255,000 | +18.1% | 10,780 | 0.0% | 0.02% | 0.0% |
Q4 2020 | $216,000 | -3.6% | 10,780 | 0.0% | 0.02% | -18.2% |
Q3 2020 | $224,000 | +14.9% | 10,780 | -3.1% | 0.02% | -18.5% |
Q2 2020 | $195,000 | +4.3% | 11,130 | -2.7% | 0.03% | 0.0% |
Q1 2020 | $187,000 | -19.7% | 11,442 | +1.0% | 0.03% | -3.6% |
Q4 2019 | $233,000 | +57.4% | 11,330 | -12.4% | 0.03% | +40.0% |
Q3 2019 | $148,000 | -12.9% | 12,930 | 0.0% | 0.02% | -20.0% |
Q2 2019 | $170,000 | -11.9% | 12,930 | +1.4% | 0.02% | -21.9% |
Q1 2019 | $193,000 | -11.9% | 12,750 | 0.0% | 0.03% | -23.8% |
Q4 2018 | $219,000 | – | 12,750 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Rubric Capital Management LP | 2,606,500 | $51,452,000 | 1.44% |
Camber Capital Management LP | 2,000,000 | $39,480,000 | 1.22% |
Eventide Asset Management | 2,629,593 | $51,908,000 | 0.68% |
GREAT POINT PARTNERS LLC | 121,342 | $2,395,000 | 0.56% |
RICE HALL JAMES & ASSOCIATES, LLC | 753,038 | $14,865,000 | 0.55% |
Values First Advisors, Inc. | 41,773 | $825,000 | 0.53% |
CLARK ESTATES INC/NY | 183,800 | $3,628,000 | 0.52% |
EMERALD MUTUAL FUND ADVISERS TRUST | 710,398 | $14,023,000 | 0.48% |
EMERALD ADVISERS, LLC | 590,256 | $11,652,000 | 0.42% |
ACORN FINANCIAL ADVISORY SERVICES INC /ADV | 68,812 | $1,358,000 | 0.42% |